EUVIMEDEUVIMED entdecken
Crossref

A Salidroside‐Based Radiosensitizer Regulates the Nrf2/ROS Pathway for X‐Ray Activated Synergistic Cancer Precise Therapy

Qingqing Li, Qing Chen, Shenggan Xiao, Shuhan Wang, Xiaoguang Ge, Qian Wang, Liting Zheng, Qiaoqiao Wei, Wei Du, Wenbin Shen, Ying Wu, Jibin Song iD

Advanced Materials · 2025-06 · 37 (24)

DOI: 10.1002/adma.202413226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 08.04.2025. Verfasst von Qingqing Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China, College of Chemistry, Fuzhou University, Fuzhou, 350108, C…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Phenols, Radiation-Sensitizing Agents, Glucosides. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hypoxic microenvironment and radioresistance of tumor cells, as well as the delay in efficacy evaluation, significantly limit the effect of clinical radiotherapy. Therefore, developing effective radiosensitizers with monitoring of tumor response is of great significance for precise radiotherapy. Herein, a novel radiosensitizer (term as: SCuFs) is developed, consisting of traditional Chinese medicine (TCM) compounds salidroside, Cu 2+ , and hydroxyl radical (•OH) activated second near‐infrared window fluorescence (NIR‐II FL) molecules, which make the radiosensitization effect and boosted chemodynamic therapy (CDT) efficacy. The overexpressed glutathione in the tumor induces the SCuFs dissociation, allowing deep penetration of the drug to the whole tumor region. After X‐ray irradiation, salidroside inhibits the Nuclear factor erythroid 2‐like 2 (Nrf2)protein expression and blocks cells in the G2/M phase with the highest radiosensitivity, which amplifies the reactive oxygen species (ROS) generation to exacerbate DNA damage, thus achieving radiosensitization. Meanwhile, the upregulated ROS provides sufficient chemical fuel for Cu + ‐mediated CDT to produce more •OH. NIR‐II FL imaging can monitor the •OH changes during the therapy process, confirming the radiosensitization effect and CDT process related to •OH. This study not only achieves effective radiosensitization and cascaded ROS‐mediated CDT efficacy, but also provides a useful tool for monitoring therapeutic efficacy, showing great prospects for clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2PhenolsRadiation-Sensitizing AgentsGlucosidesReactive Oxygen SpeciesSignal TransductionNeoplasmsAnimalsHumansMiceX-RaysCell Line, TumorCopper

Stichwörter der Autor:innen

NIR‐II fluorescenceactivatable probein vivo bioimagingradiotherapyself‐assembly

Substanzen

NF-E2-Related Factor 2PhenolsRadiation-Sensitizing AgentsrhodiolosideGlucosidesReactive Oxygen SpeciesCopper

Autor:innen und Institutionen

  • Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China, College of Chemistry, Fuzhou University, Fuzhou, 350108, China.
  • State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, 100029, China.
  • Department of Radiotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.

ORCID-Profile: Jibin Song

Förderung

  • Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Beijing Outstanding Young Scientist Program
  • National key research and development plan

Zitieren

APA

Li, Q., Chen, Q., Xiao, S., Wang, S., Ge, X., Wang, Q., Zheng, L., Wei, Q., Du, W., Shen, W., Wu, Y., & Song, J. (2025). A Salidroside‐Based Radiosensitizer Regulates the Nrf2/ROS Pathway for X‐Ray Activated Synergistic Cancer Precise Therapy. Advanced Materials, 37(24). https://doi.org/10.1002/adma.202413226

Vancouver

Li Q, Chen Q, Xiao S, Wang S, Ge X, Wang Q, et al. A Salidroside‐Based Radiosensitizer Regulates the Nrf2/ROS Pathway for X‐Ray Activated Synergistic Cancer Precise Therapy. Advanced Materials. 2025;37(24). doi:10.1002/adma.202413226

BibTeX
@article{Li2025,
  author = {Li, Qingqing and Chen, Qing and Xiao, Shenggan and Wang, Shuhan and Ge, Xiaoguang and Wang, Qian and Zheng, Liting and Wei, Qiaoqiao and Du, Wei and Shen, Wenbin and Wu, Ying and Song, Jibin},
  title = {A Salidroside‐Based Radiosensitizer Regulates the Nrf2/ROS Pathway for X‐Ray Activated Synergistic Cancer Precise Therapy},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {24},
  doi = {10.1002/adma.202413226}
}
Kostenlos starten →